BP-C2
- Generic Name
- BP-C2
Recommended Dose Estimation of BP-C2
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Meddoc
- Target Recruit Count
- 8
- Registration Number
- NCT04186585
- Locations
- 🇳🇴
Meddoc, Skjetten, Akershus, Norway
BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer
Phase 2
Completed
- Conditions
- Metastatic Pancreatic CancerUnresectable Pancreatic Cancer
- Interventions
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- Meabco A/S
- Target Recruit Count
- 16
- Registration Number
- NCT03627390
- Locations
- 🇪🇬
National Liver Institute, Menoufia University, Cairo, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath